ArticleJACC. Advances2026
Using CK-MB and hs-cTnT to Predict 30-Day Mortality After CABG: A Combined Biomarker Risk-Stratification Approach.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate diagnosis of perioperative myocardial infarction after coronary artery bypass grafting remains challenging due to uncertainty over postoperative cardiac biomarker interpretation.
objectivesThe authors aimed to evaluate the prognostic value and performance of postoperative creatine kinase-myocardial band (CK-MB) and high-sensitivity cardiac troponin T (hs-cTnT) and explore a combined approach to identify patients at risk of early death.
methodsThis multicenter cohort study involved 9,856 patients undergoing isolated coronary artery bypass grafting at hospitals in Innsbruck, Freiburg, Gothenburg, and Reykjavik. A combined biomarker matrix was created to assess synergistic effects. Associations of biomarkers with 30-day all-cause mortality were evaluated using multivariable Cox regression (adjusted HR) and area under the receiver-operating curve (AUC) analysis.
resultsThirty-day all-cause mortality was 2.0%. Median peak values within 72 hours postsurgery were 2.24 (Q1-Q3: 1.66-3.36) × upper reference limit for CK-MB and 52.06 (Q1-Q3: 29.79-90.00) × upper reference limit for hs-cTnT. Both postoperative CK-MB (adjusted HR: 1.95; 95% CI: 1.79-2.12; P < 0.001) and hs-cTnT (adjusted HR: 1.71; 95% CI: 1.61-1.82; P < 0.001) were associated with higher mortality risk per doubling in concentration independent of EuroSCORE II. Predictive accuracy of CK-MB and hs-cTnT was similar (AUC: 0.787 vs 0.784; P = 0.99), yet stratification using Youden-derived thresholds identified distinct patient subgroups with limited overlap. In a combined analysis, mortality risk was increased only when CK-MB was in the top tertile and hs-cTnT in the mid (adjusted HR: 4.34; 95% CI: 1.78-10.62; P < 0.001) or top tertile (adjusted HR: 14.78; 95% CI: 6.85-31.88; P < 0.001).
conclusionsThe combined use of CK-MB and hs-cTnT enables a simple and robust risk-stratification strategy for early postoperative mortality, with direct implications for clinical surveillance and future cardiac surgery trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.